Theralase Technologies Inc.
TLTFF
$0.1475
$0.00977.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.68% | 8.15% | 3.80% | 10.35% | 12.28% |
| Total Depreciation and Amortization | -7.90% | -6.32% | -6.85% | -9.89% | -13.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.77% | -15.76% | -13.94% | 17.77% | 63.79% |
| Change in Net Operating Assets | 279.32% | 121.81% | -82.67% | 132.62% | 37.61% |
| Cash from Operations | 37.75% | 19.13% | -4.83% | 31.09% | 21.96% |
| Capital Expenditure | -164.19% | 47.46% | 72.69% | 67.38% | 64.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -164.19% | 47.46% | 72.69% | 67.38% | 64.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.30% | 0.09% | -6.01% | -20.32% | -44.76% |
| Issuance of Common Stock | -29.00% | 33.54% | 130.47% | -10.32% | 30.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -150.00% | 100.00% | 100.00% | 100.00% |
| Cash from Financing | -31.50% | 33.63% | 135.98% | -13.50% | 26.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.69% | 115.31% | 104.20% | 101.70% | 88.81% |